Literature DB >> 11350801

Possible involvement of Rho kinase in Ca2+ sensitization and mobilization by MCh in tracheal smooth muscle.

S Ito1, H Kume, H Honjo, H Katoh, I Kodama, K Yamaki, H Hayashi.   

Abstract

We examined the effects of Rho kinase on contraction and intracellular Ca2+ concentration ([Ca2+](i)) in guinea pig trachealis by measuring isometric force and the fura 2 signal [340- to 380-nm fluorescence ratio (F340/F380)]. A Rho kinase inhibitor, Y-27632 (1-1,000 microM), inhibited methacholine (MCh)-induced contraction, with a reduction in F340/F380 in a concentration-dependent manner. The values of EC(50) for contraction and F340/F380 induced by 1 microM MCh with Y-27632 were 27.3 +/- 5.1 and 524.1 +/- 31.0 microM, respectively. With 0.1 microM MCh, the values for these parameters were decreased to 1.0 +/- 0.1 and 98.2 +/- 6.2 microM, respectively. Tension-F340/F380 curves for MCh indicated that Y-27632 caused an ~50% inhibition of MCh-induced contraction, without a reduction in F340/F380. These effects of Y-27632 were not inhibited by a protein kinase C inhibitor, GF-109203X. Our results indicate that inhibition of Rho kinase attenuates both Ca2+ sensitization and [Ca2+](i).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350801     DOI: 10.1152/ajplung.2001.280.6.L1218

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  17 in total

1.  Differential Rho-kinase dependency of full and partial muscarinic receptor agonists in airway smooth muscle contraction.

Authors:  Dedmer Schaafsma; Mark Boterman; Anne-Margreet de Jong; Iris Hovens; Jelte-Maarten Penninks; S Adriaan Nelemans; Herman Meurs; Johan Zaagsma
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

2.  Role of Airway Smooth Muscle in Inflammation Related to Asthma and COPD.

Authors:  Hiroaki Kume
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Differential inhibition by the Rho kinase inhibitor Y-27632 of the increases in contractility and Ca2+ transients induced by endothelin-1 in rabbit ventricular myocytes.

Authors:  Li Chu; Ikuo Norota; Masao Endoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-20       Impact factor: 3.000

Review 4.  cAMP regulation of airway smooth muscle function.

Authors:  Charlotte K Billington; Oluwaseun O Ojo; Raymond B Penn; Satoru Ito
Journal:  Pulm Pharmacol Ther       Date:  2012-05-24       Impact factor: 3.410

5.  Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction.

Authors:  Dedmer Schaafsma; Reinoud Gosens; I Sophie T Bos; Herman Meurs; Johan Zaagsma; S Adriaan Nelemans
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

Review 6.  Airway smooth muscle in asthma: just a target for bronchodilation?

Authors:  Judith L Black; Reynold A Panettieri; Audreesh Banerjee; Patrick Berger
Journal:  Clin Chest Med       Date:  2012-07-11       Impact factor: 2.878

Review 7.  P2 receptors in renal autoregulation.

Authors:  Zhengrong Guan; Robert C Fellner; Justin Van Beusecum; Edward W Inscho
Journal:  Curr Vasc Pharmacol       Date:  2014       Impact factor: 2.719

8.  Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter.

Authors:  Edward W Inscho; Anthony K Cook; R Clinton Webb; Li-Ming Jin
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-07

9.  Receptor-independent activation of Rho-kinase-mediated calcium sensitisation in smooth muscle.

Authors:  Sinem Ayman; Pat Wallace; Chris P Wayman; Alan Gibson; Ian McFadzean
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  Rho-kinase inhibitor inhibits both myosin phosphorylation-dependent and -independent enhancement of myofilament Ca2+ sensitivity in the bovine middle cerebral artery.

Authors:  Yoshihisa Maeda; Katsuya Hirano; Junji Nishimura; Tomio Sasaki; Hideo Kanaide
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.